Evidence map›Paper›PMID 35349750›Full record

ArticleImmunity, inflammation and disease2022

Lung donation and SARS-CoV-2 transmission: Missed detection versus missed opportunity?

Jan Van Slambrouck, Dirk Van Raemdonck, Joost Wauters, Robin Vos, Peter Mombaerts, Laurens J Ceulemans

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Immunity, inflammation and disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Transplanting COVID-19 positive donors: Expanding our experience to widen the donor pool.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2022
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jan Van SlambrouckDepartment of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.ORCID 0000-0002-7069-1535
Dirk Van RaemdonckDepartment of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.ORCID 0000-0003-1261-0992
Joost WautersMedical Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.ORCID 0000-0002-5983-3897
Robin VosLaboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.ORCID 0000-0002-3468-9251
Peter MombaertsMax Planck Research Unit for Neurogenetics, Frankfurt am Main, Germany.ORCID 0000-0001-8082-4971
Laurens J CeulemansDepartment of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.ORCID 0000-0002-4261-7100

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Point-of-care tests may play a valuable role in reducing the risk of donor-derived SARS-CoV-2 transmission in lung transplantation.

Indexed as

COVID-19SARS-CoV-2HumansLungThoraxlung transplantationNAATpoint-of-care testrapid antigen testSARS-CoV-2

Identifiers

PMID35349750
PMCPMC8939038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.